, Décret n°2006-352 du 20 mars 2006 relatif aux compléments alimentaires, 2006.
,
, « Substances à but nutritionnel ou physiologique | Synadiet
, « Plantes ou préparations de plantes | Synadiet
,
, « Les chiffres du marché en 2018 | Synadiet
Consulté le: avr, vol.19, 2020. ,
, , p.123
, Code de la santé publique -Article L5111-1, pp.5111-5112
,
,
, Arrêté du 14 juin 2006 relatif aux modalités de transmission des déclarations de première mise sur le marché des compléments alimentaires
, « Réglementation concernant la vente de compléments alimentaires
,
, Code de la consommation -Article R112-2, pp.112-114
, Additifs dans les denrées alimentaires
,
, Consulté le: avr, vol.19, 2020.
,
,
, , p.36
« Discovery pharmaceutics-Challenges and opportunities, AAPS J, vol.8, issue.2, pp.402-408, 2006. ,
,
, Astaxanthin in Exercise Metabolism, Performance and Recovery: A Review, vol.4, p.76, 2017.
, Astaxanthin in Skin Health, Repair, and Disease: A Comprehensive Review, vol.10, 2018.
A mechanistic review on its biological activities and health benefits », Pharmacol. Res, vol.136, pp.1-20, 2018. ,
« Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review, Mar Drugs, vol.12, issue.1, pp.128-152 ,
, Biological Functions and Activities of Animal Carotenoids, vol.63, pp.141-146, 1991.
« Haematococcus astaxanthin: applications for human health and nutrition, Trends Biotechnol, vol.21, issue.5, pp.210-216, 2003. ,
cell membrane nutrient with diverse clinical benefits and anti-aging potential », Altern Med Rev, vol.16, issue.4, pp.355-364, 2011. ,
, J. Nat. Prod, vol.69, issue.3, pp.443-449, 2006.
« Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae, Mol Nutr Food Res, vol.55, issue.1, pp.150-165 ,
, Crit Rev Food Sci Nutr, vol.46, issue.2, pp.185-196, 2006.
« Structure and properties of carotenoids in relation to function, FASEB J, vol.9, pp.1551-1558, 1995. ,
« Absorption, metabolism, and transport of carotenoids », FASEB J, vol.10, issue.5, pp.542-551, 1996. ,
« Bioavailability of astaxanthin in Haematococcus algal extract: the effects of timing of diet and smoking habits, Biosci. Biotechnol. Biochem, vol.73, issue.9, 1928. ,
, Scientific Opinion on the safety and efficacy of synthetic astaxanthin as feed additive for salmon and trout, other fish, EFSA Journal, vol.12, issue.6, p.3724, 2014.
, « efsa-opinion-on-the-safety-of-astaxanthin-rich-ingredients-astareal-a1010-and-astareal-l10
,
, « Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: a randomized clinical trial
, « Astaxanthin in cardiovascular health and disease: mechanisms of action, therapeutic merits, and knowledge gaps
« Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: a randomized clinical trial », J Med Food, vol.6, issue.1, pp.51-56, 2003. ,
« Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations », Eur J Pharm Sci, vol.19, issue.4, pp.299-304, 2003. ,
« The in vitro effects of Xancor, a synthetic astaxanthine derivative, on hemostatic biomarkers in aspirin-naïve and aspirin-treated subjects with multiple risk factors for vascular disease », Am J Ther, vol.17, issue.2, pp.125-132 ,
Producing Green Microalga Haematococcus pluvialis: From Single Cell to High Value Commercial Products, Front Plant Sci, vol.7, p.531, 2016. ,
« Microalgal Carotenoids: A Review of Production, Current Markets, Regulations, and Future Direction, Mar Drugs, vol.17, issue.11, 2019. ,
« Characterization of microalgal carotenoids by mass spectrometry and their bioavailability and antioxidant properties elucidated in rat model, J. Agric. Food Chem, vol.58, pp.8553-8559, 2010. ,
, , 2020.
« Oxidation events and skin aging, Ageing Res. Rev, vol.21, pp.16-29, 2015. ,
, « Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits
« In vivo bioavailability and antioxidant activity of carotenoids from microalgal biomass -A repeated dose study, Food Research International, vol.54, issue.1, pp.711-717, 2013. ,
« Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges, Immun Ageing, vol.13, p.16, 2016. ,
, Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin, vol.22, 2020.
« Effect of astaxanthin in combination with alpha-tocopherol or ascorbic acid against oxidative damage in diabetic ODS rats, J. Nutr. Sci. Vitaminol, vol.54, issue.4, pp.329-334, 2008. ,
Apoptosis and Langerhans cells -Activators of UV-induced Immune Tolerance, 2020. ,
Who's on first in the cellular response to DNA damage?, Nat Rev Mol Cell Biol, vol.4, issue.5, pp.2003-45361, 2003. ,
canthaxanthin and beta-carotene differently affect UVAinduced oxidative damage and expression of oxidative stress-responsive enzymes, Exp. Dermatol, vol.18, issue.3, pp.222-231, 2009. ,
, Apoptosis: mechanisms and clinical implications », Anaesthesia, vol.55, pp.1081-1093, 2000.
« Multiple Mechanisms of Anti-Cancer Effects Exerted by ,
, Mar Drugs, vol.13, pp.4310-4330, 2015.
« Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells, Cancer Lett, vol.283, issue.1, pp.108-117, 2009. ,
« A systematic review of anti-obesity medicinal plants -an update, J Diabetes Metab Disord, vol.12, issue.1, p.28, 2013. ,
« Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice, Redox Rep, vol.7, issue.5, pp.290-293, 2002. ,
, Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion », Toxicology, vol.267, pp.147-153
« Protective effect of astaxanthin on liver fibrosis through modulation of TGF-?1 expression and autophagy, Mediators Inflamm, vol.2014, p.954502, 2014. ,
« Astaxanthin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells via Inhibition of Nf-?b P65 and Wnt/?-Catenin in Vitro, Mar Drugs, vol.13, issue.10, pp.6064-6081, 2015. ,
« Neuroprotective effects of astaxanthin in a rat model of spinal cord injury, Behav. Brain Res, vol.329, pp.104-110, 2017. ,
« The antioxidant effect of astaxanthin is higher in young mice than aged: a region specific study on brain, Metab Brain Dis, vol.30, pp.1237-1246, 2015. ,
« Astaxanthin improves cognitive deficits from oxidative stress, nitric oxide synthase and inflammation through upregulation of PI3K/Akt in diabetes rat », Int J Clin Exp Pathol, vol.8, issue.6, pp.6083-6094, 2015. ,
Coenzyme Q10 a-t-il un intérêt comme adjuvant du traitement par statines ?, p.157 ,
, Safety assessment of coenzyme Q10 (CoQ10) », Biofactors, vol.32, pp.199-208, 2008.
Co-enzyme Q10: a new drug for cardiovascular disease, J Clin Pharmacol, vol.30, issue.7, pp.596-608 ,
, Clinical applications of coenzyme Q10 », Front Biosci, vol.19, pp.619-633, 2014.
« Functional connections and pathways of coenzyme Q10-inducible genes: an in-silico study, IUBMB Life, vol.59, issue.10, pp.628-633, 2007. ,
, « The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start? -PubMed -NCBI
« Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy », Eur. J. Neurol, vol.15, pp.1371-1379 ,
« Antioxidants in the treatment of diabetes, Curr Diabetes Rev, vol.7, issue.2, pp.106-125, 2011. ,
« Coenzyme Q10 for Parkinson's disease », Cochrane Database Syst Rev, vol.12, p.8150, 2011. ,
« Health benefits of docosahexaenoic acid (DHA) », Pharmacol. Res, vol.40, issue.3, pp.211-225, 1999. ,
, Les rôles physiologiques majeurs exercés par les acides gras polyinsaturés (AGPI) », Oléagineux, Corps gras, Lipides, vol.12, 2005.
« Acides gras polyinsaturés n-3 (AGPI n-3) e prévention des dommages cérébraux induits par un stress chronique, p.417 ,
« Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults », Reproduction, nutrition, development, vol.45, pp.581-97, 2005. ,
« Lipid metabolic enzymes: emerging drug targets for the treatment of obesity, Nat Rev Drug Discov, vol.3, issue.8, pp.695-710, 2004. ,
« Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations -A comparative bioavailability study of fish oil vs. krill oil », Lipids in health and disease, vol.10, p.145, 2011. ,
C22:6 n-3). ROLE DES DESATURASES, p.61 ,
Consulté le: avr, vol.23, 2020. ,
, « Omega-3 DHA -Dossier complet -Bienfaits et posologie », Doctonat, juin 16, 2019.
« Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor », Pharmacol. Res, vol.55, issue.3, pp.217-223, 2007. ,
« Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial », J. Am. Coll. Cardiol, vol.61, issue.4, pp.463-468 ,
« (n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?123 », J Nutr, vol.142, issue.3, pp.614-625, 2012. ,
« ?3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4, J. Mol. Cell. Cardiol, vol.103, pp.74-92, 2017. ,
« Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the, American Heart Association, vol.135, pp.867-884, 2017. ,
« Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, Lancet, vol.372, pp.61239-61247, 2008. ,
« Omega-3 Fatty acids for cardiovascular disease prevention, Curr Treat Options Cardiovasc Med, vol.12, issue.4, pp.365-380, 2010. ,
,
, Relevance for cardiovascular outcomes », Nutrition, Metabolism and Cardiovascular Diseases, vol.27, pp.191-200, 2017.
« Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits, Annu Rev Food Sci Technol, vol.9, pp.345-381, 2018. ,
« Diet and lung cancer risk from a 14-year population-based prospective study in Japan: with special reference to fish consumption, Nutr Cancer, vol.45, issue.2, pp.160-167, 2003. ,
« Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis », JNCI J Natl Cancer Inst, vol.109, issue.3, p.2017 ,
« Dietary fat-gene interactions in cancer, Cancer Metastasis Rev, vol.26, pp.535-551 ,
« Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms, Am. J. Clin. Nutr, vol.79, issue.6, pp.935-945, 2004. ,
« Effects of omega-3 fatty acids on cancer risk: a systematic review, JAMA, vol.295, issue.4, pp.403-415, 2006. ,
« The importance of the ratio of omega-6/omega-3 essential fatty acids, Biomed. Pharmacother, vol.56, issue.8, pp.365-379, 2002. ,
« Fatty fish consumption and risk of prostate cancer, Lancet, vol.357, pp.4889-4892, 2001. ,
« Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies, BMJ, vol.346, p.3706, 2013. ,
« Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids, J. Clin. Invest, vol.117, issue.7, pp.1866-1875, 2007. ,
« Arachidonic acid and cancer risk: a systematic review of observational studies, BMC Cancer, vol.12, p.606 ,
A Good Idea for Reduction of Mastalgia ,
, Risk of Breast Cancer », Focus on Sciences, vol.3, pp.1-7, 2017.
« Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells, Macromol Biosci, vol.17, 2017. ,
, « Omega-3 fatty acids and dementia. -PubMed -NCBI, vol.23, 2020.
, Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial
, « Omega-3 treatment of childhood depression: a controlled, double-blind pilot study
« A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age, Lipids, vol.42, issue.2, pp.117-122, 2007. ,
« Dietary PUFA for preterm and term infants: review of clinical studies, Crit Rev Food Sci Nutr, vol.45, issue.3, pp.205-229, 2005. ,
« The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials, Am. J. Clin. Nutr, vol.97, issue.3, pp.531-544, 2013. ,
, Encyclopedia of Food Chemistry, 2018.
« DHA supplementation and pregnancy outcomes », Am. J. Clin. Nutr, vol.97, issue.4, pp.808-815, 2013. ,
« High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish, Epidemiology, vol.20, issue.4, pp.598-603, 2009. ,
« Encapsulation de molécules hydrophobes par des structures bi-gels générées par prilling: relation structure-propriétés, p.254 ,
, Ref : TIP453WEB -« Formulation, vol.10, 2013.
, Cyclodextrins in drug delivery: an updated review, vol.6, pp.329-357, 2005.
, « Les cyclodextrines : des écrins moléculaires
, , p.224
« Administration par voie orale des composes BCS classe II: réponses galéniques au problème de la faible solubilité aqueuse, p.158 ,
« Administration par voie orale des composes BCS classe II: réponses galéniques au problème de la faible solubilité aqueuse, p.158 ,
« Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs, International Journal of Pharmaceutics, vol.106, issue.1, pp.90271-90273, 1994. ,
Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification, International Journal of Pharmaceutics, vol.27, issue.2, pp.335-348 ,
, « Nanoparticle technology for drug delivery across the blood-brain barrier
« A review: Using nanoparticles to enhance absorption and bioavailability of phenolic phytochemicals, Food Hydrocolloids, vol.43, pp.153-164, 2015. ,
« Nanoparticle Formulation Increases Oral Bioavailability of Poorly Soluble Drugs: Approaches Experimental Evidences and Theory, Curr Nanosci, vol.1, issue.3, pp.237-243, 2005. ,
, Current Opinion in Colloid & Interface Science, vol.10, pp.102-110, 2005.
, Emulsion Formation, Stability, and Rheology, pp.1-75, 2013.
« Nanoencapsulation of docosahexaenoic acid (DHA) using a combination of food grade polymeric wall materials and its application for improvement in bioavailability and oxidative stability, Food Funct, vol.9, issue.4, pp.2213-2227, 2018. ,
« Astaxanthin from Phaffia rhodozyma: Microencapsulation with carboxymethyl cellulose sodium and microcrystalline cellulose and effects of microencapsulated astaxanthin on yogurt properties, vol.96, pp.152-160, 2018. ,
« Evaluation of the physicochemical stability and digestibility of microencapsulated esterified astaxanthins using in vitro and in vivo models, Food Chemistry, vol.260, pp.73-81, 2018. ,
« Water-dispersible astaxanthin-rich nanopowder: preparation, oral safety and antioxidant activity in vivo, Food Funct, vol.10, issue.3, pp.1386-1397, 2019. ,
« Nanoparticle formation of PVP/astaxanthin inclusion complex by solutionenhanced dispersion by supercritical fluids (SEDS): Effect of PVP and astaxanthin Z-isomer content, The Journal of Supercritical Fluids, vol.136, pp.44-51, 2018. ,
« Improved aqueous solubility of crystalline astaxanthin (3,3'-dihydroxy-beta, beta-carotene-4,4'-dione) by Captisol (sulfobutyl ether betacyclodextrin), J Pharm Sci, vol.92, issue.4, pp.922-926, 2003. ,
« Coenzyme Q10 -gamma cyclodextrin complex is a powerful nutraceutical for anti-aging and health improvements, Biomed Res Clin Prac, vol.2, issue.1, 2017. ,
, Property Studies of Coenzyme Q10-Cyclodextrins complexes, p.7, 2009.
« Studies of CoQ10 and cyclodextrin complexes: solubility, thermo-and photo-stability, J Incl Phenom Macrocycl Chem, vol.64, issue.3, pp.225-232, 2009. ,
« Micelle formation of coenzyme Q10 with dipotassium glycyrrhizate using inclusion complex of coenzyme Q10 with ?-cyclodextrin », J Phys Chem B, vol.118, pp.11480-11486, 2014. ,
« Relative bioavailability of two forms of a novel water-soluble coenzyme Q10, Ann. Nutr. Metab, vol.52, issue.4, pp.281-287, 2008. ,
« Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems », Int J Pharm, vol.374, issue.2, pp.66-72, 2009. ,
« Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment », Int J Pharm, vol.212, issue.2, pp.233-246, 2001. ,
« Development of Self-emulsifying DHA Formulation, p.5 ,
Sang, « Characterization and pharmacokinetics of coenzyme Q10 nanoparticles prepared by a rapid expansion of supercritical solution process, Pharmazie, vol.67, issue.2, pp.161-167 ,
« Preparation, in-vitro and in-vivo characterisation of CoQ10 microparticles: electrospraying-enhanced bioavailability », J. Pharm. Pharmacol, vol.68, issue.2, pp.159-169, 2016. ,
« Development of food-grade nanoemulsions and emulsions for delivery of omega-3 fatty acids: opportunities and obstacles in the food industry, Food Funct, vol.6, issue.1, pp.42-55, 2015. ,
« Changes in Bioavailability of Omega-3 (DHA) through Alpha-Tocopheryl Phosphate Mixture (TPM) after Oral Administration in Rats, Nutrients, vol.9, issue.9, 2017. ,
« Coenzyme Q10 solubility in supercritical CO2 using a dynamic system, Journal of CO2 Utilization, vol.24, pp.315-320, 2018. ,
« Enhanced water dispersibility of coenzyme Q10 by complexation with albumin hydrolysate, J. Agric. Food Chem, vol.61, pp.5972-5978, 2013. ,
« Novel lipid-free nanoformulation for improving oral bioavailability of coenzyme Q10, Biomed Res Int, vol.2014, p.793879, 2014. ,
« PEGylated Solanesol for Oral Delivery of Coenzyme Q10 », J. Agric. Food Chem, vol.65, pp.3360-3367, 2017. ,